GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » FCF Yield %

ImmunoPrecise Antibodies (STU:TQB) FCF Yield % : -35.02 (As of Apr. 17, 2025)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, ImmunoPrecise Antibodies's Trailing 12-Month Free Cash Flow is €-6.40 Mil, and Market Cap is €17.31 Mil. Therefore, ImmunoPrecise Antibodies's FCF Yield % for today is -35.02%.

The historical rank and industry rank for ImmunoPrecise Antibodies's FCF Yield % or its related term are showing as below:

STU:TQB' s FCF Yield % Range Over the Past 10 Years
Min: -62.41   Med: -8.52   Max: 0.13
Current: -35.02


During the past 13 years, the highest FCF Yield % of ImmunoPrecise Antibodies was 0.13%. The lowest was -62.41%. And the median was -8.52%.

STU:TQB's FCF Yield % is ranked worse than
67.56% of 1498 companies
in the Biotechnology industry
Industry Median: -15.525 vs STU:TQB: -35.02

ImmunoPrecise Antibodies's FCF Margin % for the quarter that ended in Jan. 2025 was -21.39%.


ImmunoPrecise Antibodies FCF Yield % Historical Data

The historical data trend for ImmunoPrecise Antibodies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies FCF Yield % Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -23.60 -12.41

ImmunoPrecise Antibodies Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.37 -33.16 -28.95 -49.61 -17.78

Competitive Comparison of ImmunoPrecise Antibodies's FCF Yield %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's FCF Yield % falls into.


;
;

ImmunoPrecise Antibodies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

ImmunoPrecise Antibodies's FCF Yield % for the fiscal year that ended in Apr. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.846 / 30.98675
=-12.41%

ImmunoPrecise Antibodies's annualized FCF Yield % for the quarter that ended in Jan. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.883 * 4 / 19.86201
=-17.78%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


ImmunoPrecise Antibodies FCF Yield % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

ImmunoPrecise Antibodies Headlines

No Headlines